Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
3.880
-0.180 (-4.43%)
At close: Sep 12, 2025, 4:00 PM EDT
3.940
+0.060 (1.55%)
After-hours: Sep 12, 2025, 7:35 PM EDT
Bionano Genomics Market Cap
Bionano Genomics has a market cap or net worth of $18.16 million as of September 12, 2025. Its market cap has decreased by -59.53% in one year.
Market Cap
18.16M
Enterprise Value
20.48M
1-Year Change
-59.53%
Ranking
Category
Stock Price
$3.88
Market Cap Chart
Since September 21, 2018, Bionano Genomics's market cap has decreased from $66.34M to $18.16M, a decrease of -72.62%. That is a compound annual growth rate of -16.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2025 | 19.00M | -35.39% |
| Dec 31, 2024 | 29.41M | -59.93% |
| Dec 29, 2023 | 73.41M | -83.07% |
| Dec 30, 2022 | 433.51M | -49.86% |
| Dec 31, 2021 | 864.66M | 83.26% |
| Dec 31, 2020 | 471.81M | 1,336.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 680.03B |
| Johnson & Johnson | 427.77B |
| AbbVie | 388.87B |
| UnitedHealth Group | 324.67B |
| AstraZeneca | 250.26B |
| Novo Nordisk | 244.96B |
| Novartis AG | 244.56B |
| Abbott Laboratories | 228.71B |